IL155965A0 - Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative - Google Patents

Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative

Info

Publication number
IL155965A0
IL155965A0 IL15596501A IL15596501A IL155965A0 IL 155965 A0 IL155965 A0 IL 155965A0 IL 15596501 A IL15596501 A IL 15596501A IL 15596501 A IL15596501 A IL 15596501A IL 155965 A0 IL155965 A0 IL 155965A0
Authority
IL
Israel
Prior art keywords
imidazole
pharmaceutical compositions
compositions containing
acid derivative
pharmacologically acceptable
Prior art date
Application number
IL15596501A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26604360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL155965(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL155965A0 publication Critical patent/IL155965A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
IL15596501A 2000-11-21 2001-11-19 Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative IL155965A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000354327 2000-11-21
JP2001164009 2001-05-31
PCT/JP2001/010095 WO2002041890A1 (fr) 2000-11-21 2001-11-19 Compositions medicinales

Publications (1)

Publication Number Publication Date
IL155965A0 true IL155965A0 (en) 2003-12-23

Family

ID=26604360

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15596501A IL155965A0 (en) 2000-11-21 2001-11-19 Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative
IL155965A IL155965A (en) 2000-11-21 2003-05-18 Pharmaceutical preparations containing the result of imidazole converted in position - 5 - in carboxylic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155965A IL155965A (en) 2000-11-21 2003-05-18 Pharmaceutical preparations containing the result of imidazole converted in position - 5 - in carboxylic acid

Country Status (24)

Country Link
US (2) US6878703B2 (de)
EP (2) EP1336407B1 (de)
KR (1) KR100656716B1 (de)
CN (1) CN1265788C (de)
AT (1) ATE324890T1 (de)
AU (2) AU1432402A (de)
BR (1) BR0115516A (de)
CA (1) CA2429260A1 (de)
CY (1) CY1106134T1 (de)
CZ (1) CZ20031367A3 (de)
DE (1) DE60119368T2 (de)
DK (1) DK1336407T3 (de)
ES (1) ES2262689T3 (de)
HK (1) HK1054692A1 (de)
HU (1) HUP0400553A3 (de)
IL (2) IL155965A0 (de)
MX (1) MXPA03004463A (de)
NO (1) NO332938B1 (de)
NZ (1) NZ525913A (de)
PL (1) PL207252B1 (de)
PT (1) PT1336407E (de)
SK (1) SK5992003A3 (de)
TW (1) TWI262076B (de)
WO (1) WO2002041890A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004208615C1 (en) * 2003-01-31 2010-05-13 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
US7282519B2 (en) 2003-08-28 2007-10-16 Nitromed, Inc. Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
EP1784398A1 (de) * 2004-09-02 2007-05-16 Teva Pharmaceutical Industries Ltd Aufreinigung von olmesartan-medoxomil
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CA2573800A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Preparation of olmesartan medoxomil
US7396829B2 (en) 2005-02-24 2008-07-08 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
JP4979577B2 (ja) * 2005-05-20 2012-07-18 第一三共株式会社 デキストロース含有フィルムコーティング製剤
TWI367755B (en) * 2005-05-20 2012-07-11 Sankyo Co Film coated product
WO2007047838A2 (en) * 2005-10-20 2007-04-26 Dr. Reddy's Laboratories Ltd. Process for preparing olmesartan medoxomil
US8077769B2 (en) * 2006-03-28 2011-12-13 Sony Corporation Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach
EP1891952B1 (de) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmazeutische Zusammensetzung mit Olmesartan-Medoxomil
EP2079452A4 (de) * 2006-10-30 2010-01-06 Hanall Pharmaceutical Co Ltd Thiazide und angiotensin-ii-rezeptorblocker enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung
WO2009113420A1 (ja) 2008-03-13 2009-09-17 第一三共株式会社 オルメサルタンメドキソミルを含む製剤の溶出性の改善
US20100008956A1 (en) * 2008-07-08 2010-01-14 Jie Du Composition and combinations of carboxylic acid losartan in dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US9387249B2 (en) 2008-12-23 2016-07-12 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
US11081240B2 (en) 2018-06-14 2021-08-03 Astrazeneca Uk Limited Methods for treatment of hypertension with an angiotensin II receptor blocker pharmaceutical composition

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3009911A (en) 1961-11-21 Derivatives of j
US2976289A (en) 1961-03-21 X-tetrahydro -
US3025292A (en) * 1962-03-13 Reduction of i
US3108097A (en) * 1963-10-22 Ehnojs
US3254076A (en) 1966-05-31 Sulfamyl hydro
US2783241A (en) 1957-02-26 S-acylimino-x-substituted-az-i
US2554816A (en) 1950-04-04 1951-05-29 American Cyanamid Co Heterocyclic sulfonamides and methods of preparation thereof
GB795174A (en) 1954-10-13 1958-05-21 Upjohn Co Heterocyclic sulphonamides
US2835702A (en) 1956-05-02 1958-05-20 Merck & Co Inc Benzene 1, 3 disulfonamides possessing diuretic properties
US2980679A (en) 1957-04-04 1961-04-18 Omikron Gagliardi Societa Di F Process for preparing heterocyclic sulfonamides
US3055904A (en) 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
GB851287A (en) 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
GB979994A (en) * 1961-07-28 1965-01-06 May & Baker Ltd Isoindolinone derivatives
US3265573A (en) 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
NL299931A (de) 1962-10-30
DE1278443C2 (de) 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
US3163645A (en) 1964-09-25 1964-12-29 Ciba Geigy Corp Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides
DE1270544B (de) * 1965-06-19 1968-06-20 Beiersdorf Ag 4-Chlor-5-sulfamylsalicylsaeure-(2', 6'-dimethyl)-anilid und dessen Alkali- oder Ammonium-Salze sowie Verfahren zu deren Herstellung
US3360518A (en) * 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
US3634583A (en) * 1969-07-24 1972-01-11 Leo Pharm Prod Ltd Pharmaceutical composition for the treatment of oedematous conditions and hypertension
BE757001A (fr) 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
EP0733366B1 (de) * 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Angiotensin II-Rezeptor blockierende Imidazole und Diuretika enthaltende pharmazeutische Zusammensetzungen
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0400835A1 (de) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituierte Benzimidazole als Angiotensin II-Hemmer
US5656650A (en) * 1990-12-14 1997-08-12 Smithkline Beecham Corp. Angiotensin II receptor blocking compositions
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
IS1756B (is) * 1991-02-21 2000-12-28 Sankyo Company Limited Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist

Also Published As

Publication number Publication date
CA2429260A1 (en) 2002-05-30
US20040002529A1 (en) 2004-01-01
DE60119368T2 (de) 2007-05-03
DE60119368D1 (de) 2006-06-08
SK5992003A3 (en) 2003-11-04
AU1432402A (en) 2002-06-03
ATE324890T1 (de) 2006-06-15
CN1265788C (zh) 2006-07-26
AU2002214324B2 (en) 2004-07-29
HUP0400553A2 (hu) 2004-06-28
EP1336407A1 (de) 2003-08-20
MXPA03004463A (es) 2003-08-19
PL361093A1 (en) 2004-09-20
NO332938B1 (no) 2013-02-04
TWI262076B (en) 2006-09-21
HK1054692A1 (en) 2003-12-12
PT1336407E (pt) 2006-07-31
ES2262689T3 (es) 2006-12-01
KR100656716B1 (ko) 2006-12-13
HUP0400553A3 (en) 2010-03-29
KR20030096235A (ko) 2003-12-24
CZ20031367A3 (cs) 2003-10-15
DK1336407T3 (da) 2006-09-04
EP1336407B1 (de) 2006-05-03
NO20032261D0 (no) 2003-05-20
US6878703B2 (en) 2005-04-12
IL155965A (en) 2008-08-07
EP1336407A4 (de) 2004-07-14
WO2002041890A1 (fr) 2002-05-30
CN1486182A (zh) 2004-03-31
BR0115516A (pt) 2004-02-03
US20050113367A1 (en) 2005-05-26
NZ525913A (en) 2004-05-28
PL207252B1 (pl) 2010-11-30
NO20032261L (no) 2003-07-09
EP1595540A1 (de) 2005-11-16
CY1106134T1 (el) 2011-06-08

Similar Documents

Publication Publication Date Title
IL155965A0 (en) Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
YU68102A (sh) Derivati karboksilne kiseline kao ip antagonisti
IL192605A0 (en) 1,2-dihydropyridin-2-one derivatives and pharmaceutical compositions containing the same
ATE204873T1 (de) Naphthyridinderivate als angiotensin-ii- antagonist-inhibitoren
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
NZ331060A (en) Quinoxalinediones, preparation and pharmaceutical compositions thereof
WO2001090097A3 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
WO2003049690A3 (en) Hiv integrase inhibitors
WO2003082192A3 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
IL136100A (en) Biphenylamidine derivatives and pharmaceutical compositions containing the same
HK1019334A1 (en) 2-(arylphenyl) amino-imidazoline derivatives
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
WO2002062798A3 (en) Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
TW375525B (en) Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
TR200003171T2 (tr) 1-[(1-ikameli-4-piperidinyl)methyl]-4-piperidine türevi, hazırlanma prosesi, bu türevi içeren farmasötik terkip ve ara ürünü